Xarelto

rivaroxaban · Bayer/Janssen Pharmaceuticals (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

141 regulatory and trial events tracked for Xarelto, covering 2011-04-08 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty [NA]